THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?

The bioavailability levels of cannabidiol (CBD) and tetrahydrocannabinol (THC) determine their pharmacological effects. Therefore, for medical purposes, it is essential to obtain extracts containing the lowest possible content of the psychogenic component THC. In our extract, the CBD/THC ratio was 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartkowiak-Wieczorek, Joanna, Mądry, Edyta, Książkiewicz, Michał, Winkler-Galicki, Jakub, Szalata, Milena, Szalata, Marlena, Jiménez, Ulises Elizalde, Wielgus, Karolina, Grześkowiak, Edmund, Słomski, Ryszard, Bienert, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304291/
https://www.ncbi.nlm.nih.gov/pubmed/37375550
http://dx.doi.org/10.3390/nu15122646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304291/
https://www.ncbi.nlm.nih.gov/pubmed/37375550
http://dx.doi.org/10.3390/nu15122646

Ejemplares similares